Nanoparticle vaccine could curb cancer metastasis to lungs by targeting a protein

Researchers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. The key ingredients of the vaccine are nanoparticles - fashioned from bacterial viruses - that have been engineered to target a protein known to play a central role in cancer growth and spread.